D T Dicheva
Overview
Explore the profile of D T Dicheva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Andreev D, Bordin D, Vyuchnova E, Lebedeva E, Dicheva D, Umyarova R, et al.
Ter Arkh
. 2022 Oct;
94(9):1099-1108.
PMID: 36286762
Aim: To systematize data on the prevalence of the combination of functional dyspepsia (FD) and irritable bowel syndrome (IBS) using the Rome IIIIV Criteria. Materials And Methods: A search in...
2.
Maev I, Mkrtumyan A, Bektemirova L, Andreev D, Dicheva D
Ter Arkh
. 2022 Oct;
94(2):209-215.
PMID: 36286745
Aim: Evaluation of the efficacy and safety of eradication therapy of infection Helicobacter pylori in patients with H. pylori- associated pathology of the upper gastrointestinal tract and concomitant type 2...
3.
Veliev A, Maev I, Andreev D, Dicheva D, Zaborovskii A, Lobanova E, et al.
Ter Arkh
. 2020 Jun;
91(8):28-33.
PMID: 32598751
Aim: Evaluation of the efficacy and safety of quadrupletherapy without bismuth (concomitant therapy) in patients with Helicobacter pylori - associated gastric ulcer and duodenal ulcer in the framework of a...
4.
Maev I, Kuznetsova E, Andreev D, Dicheva D
Ter Arkh
. 2020 Jun;
92(2):24-28.
PMID: 32598714
Aim: Assessment of the diagnostic accuracy of predictive indexes of liver fibrosis for the identification of severe fibrosis and cirrhosis (F3F4) in patients with chronic hepatitis C (CHC). Materials And...
5.
Yurenev G, Partzvania-Vinogradova E, Andreev D, Dicheva D, Maiev I
Ter Arkh
. 2019 Feb;
90(8):33-39.
PMID: 30701937
Aim: The aim is to conduct a comprehensive comparative study of the efficacy and safety of the hybrid scheme of eradication therapy (ET) in patients with peptic ulcer of the...
6.
Andreev D, Maev I, Dicheva D, Samsonov A, Partzvania-Vinogradova E
Ter Arkh
. 2019 Feb;
90(8):27-32.
PMID: 30701936
Aim: To evaluate the effectiveness and safety of the use of rebamipide as part of the triple eradication therapy (ET) scheme of Helicobacter pylori infection. Materials And Methods: A prospective,...
7.
Kazyulin A, Dicheva D, Parcvania-Vinogradova E, Andreev D
Eksp Klin Gastroenterol
. 2018 Oct;
(6):100-4.
PMID: 30280848
Conducting daily pH monitoring in patients with asthma has a number of features. Due to the fact that the introduction of the pH probe in such patients may provoke an...
8.
Andreev D, Dicheva D, Maev I
Ter Arkh
. 2017 Apr;
89(2):84-90.
PMID: 28393827
A steady decline in the effectiveness of standard eradication therapy (ET) regimens for Helicobacter pylori infection necessitates a search for ways of their optimization, by enhancing the efficiency of treatment...
9.
Andreev D, Maev I, Kucheryavyi Y, Dicheva D, Partsvania-Vinogradova E
Ter Arkh
. 2016 Apr;
88(4):75-81.
PMID: 27070167
Aim: To evaluate the efficiency and safety of two eradication therapy (ET) regimens for Helicobacter pylori infection in patients with concomitant chronic hepatitis C (CHC) in relation to the stage...
10.
Maev I, Andreev D, Dicheva D, Kaznacheeva T
Klin Med (Mosk)
. 2015 Oct;
93(6):25-30.
PMID: 26495523
Intrahepatic cholestasis of pregnancy (ICP) is a relatively benign cholestatic pathology of the liver developing in II or III trimester of pregnancy and characterized by itchy skin and enhanced serum...